Digena Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 53

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Latest Deal Amount
  • $22.2M

Digena General Information

Description

Developer of molecular diagnostic equipment and diagnostic kits designed for high-end gene analysis tools. The company focuses on the research and development of molecular diagnostic equipment, detection reagents and other related products in the field of in-vitro diagnostic products (IVD). The company's self-developed DP-TOF time-of-flight mass spectrometer of nucleic acid is the first approved general-purpose nucleic acid mass spectrometer in China, providing laboratories and hospitals with gene detection platforms and diagnostic products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building 9, No. 355, Xingzhong Road
  • Yuhang Economic and Technological Development Zone, Yuhang District
  • Hangzhou, Zhejiang
  • China
+86 400
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • 2nd Floor, Building 9, No. 355, Xingzhong Road
  • Yuhang Economic and Technological Development Zone, Yuhang District
  • Hangzhou, Zhejiang
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Digena Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 07-Sep-2026 $22.2M Announced Generating Revenue
4. Secondary Transaction - Private 08-Aug-2026 Completed Generating Revenue
3. Secondary Transaction - Private 02-Apr-2026 Completed Generating Revenue
2. Early Stage VC (Series B) 14-Mar-2022 $15.8M $15.8M Completed Generating Revenue
1. Early Stage VC (Series A) 28-Oct-2020 Completed Generating Revenue
To view Digena’s complete valuation and funding history, request access »

Digena Patents

Digena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4016379-A1 Nucleic acid mass spectrum numerical processing method Active 10-Feb-2020
EP-4016379-A4 Nucleic acid mass spectrum numerical processing method Active 10-Feb-2020
EP-4016379-B1 Nucleic acid mass spectrum numerical processing method Active 10-Feb-2020
EP-4016379-C0 Nucleic acid mass spectrum numerical processing method Active 10-Feb-2020
US-20220383979-A1 Nucleic acid mass spectrum numerical processing method Pending 10-Feb-2020 G16B30/00
To view Digena’s complete patent history, request access »

Digena Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Digena FAQs

  • When was Digena founded?

    Digena was founded in 2018.

  • Where is Digena headquartered?

    Digena is headquartered in Hangzhou, China.

  • What is the size of Digena?

    Digena has 53 total employees.

  • What industry is Digena in?

    Digena’s primary industry is Diagnostic Equipment.

  • Is Digena a private or public company?

    Digena is a Private company.

  • What is the current valuation of Digena?

    The current valuation of Digena is .

  • What is Digena’s current revenue?

    The current revenue for Digena is .

  • How much funding has Digena raised over time?

    Digena has raised $15.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process